• IBS-D: diarrhea-predominant
• IBS-C: constipation-predominant
• IBS-M: mixed bowel habit

Practical first-line approach

1. Diet and lifestyle
   • Keep a 2-4 week symptom and food diary.
   • Eat regular meals, avoid rushing meals, and limit common triggers: excess alcohol, caffeine, fizzy drinks, fatty/spicy foods, and sugar alcohols such as sorbitol.
   • A dietitian-guided low-FODMAP trial for 2-6 weeks can be useful, followed by structured food reintroduction rather than permanent severe restriction. It mainly improves bloating and pain.
   • Prefer soluble fibre such as psyllium/ispaghula or oats, especially for constipation or mixed IBS. Avoid adding wheat bran or other insoluble fibre if it worsens gas or pain.
   • Regular physical activity, adequate sleep, and addressing stress often improve symptoms.
2. For abdominal cramps/pain
   • A clinician may recommend an antispasmodic as needed, such as peppermint oil or prescription antispasmodic medication, depending on your country and medical history.
   • If symptoms persist, low-dose tricyclic antidepressants can reduce gut pain, but these should be prescribed and monitored by a clinician. They can worsen constipation.
3. If diarrhea-predominant IBS
   • Loperamide can be used for diarrhea control, titrated to produce soft, formed stools. It helps urgency and frequency but may not relieve pain or bloating.
   • Persistent IBS-D may need gastroenterology review for options such as rifaximin, bile-acid treatment when appropriate, or other prescription therapies.
   • Avoid loperamide and seek medical advice if there is fever, bloody stool, severe pain, or suspected infection.
4. If constipation-predominant IBS
   • Start with soluble fibre plus water. An osmotic laxative such as polyethylene glycol may help stool frequency, though it may not fully treat pain/bloating.
   • If inadequate, a clinician may consider prescription options such as linaclotide, lubiprostone, or other locally available agents.
5. Mind-gut treatment
   • Gut-directed CBT, relaxation therapy, or hypnotherapy can be effective for ongoing symptoms, particularly when stress, anxiety, or symptom-related avoidance is prominent. This is a treatment for gut-brain signaling, not an implication that symptoms are “all in the mind.”

Probiotics

When to see a doctor promptly

• blood in stool or black stool
• unintentional weight loss
• anemia, persistent fever, or waking at night with diarrhea/pain
• new onset after age 50
• family history of colorectal cancer, inflammatory bowel disease, or celiac disease
• persistent vomiting, severe worsening pain, or dehydration.

Core plan

• Eat regular meals and keep a 2-4 week diary of stool type, pain, stress, and foods.
• Trial a low-FODMAP diet for 2-6 weeks, ideally with a dietitian, then reintroduce foods to identify personal triggers.
• Use soluble fibre, especially psyllium/ispaghula, starting with a small amount and increasing slowly with fluids. Oats are another option. Avoid bran if it increases gas, bloating, or cramps.
• Exercise, sleep, and stress management matter. CBT or gut-directed hypnotherapy can help persistent pain and bowel symptoms.

Medication according to the current symptom

Avoid

• Taking loperamide every day if you are frequently constipated.
• High doses of fibre introduced quickly.
• Long-term, highly restrictive low-FODMAP dieting without food reintroduction.
• Using antibiotics, supplements, or probiotics as a routine cure. Probiotic evidence is inconsistent; if trying one, use one product for about 4 weeks and stop if it has no clear benefit. A 2024 review suggests possible benefit but does not identify a reliably best product (probiotic review, PMID 38479936).

Get medical review rather than self-treating if you have

What to do

• Have smaller, regular meals rather than large meals.
• Reduce common post-meal triggers for 1-2 weeks: coffee, energy drinks, alcohol, high-fat foods, very spicy foods, fizzy drinks, and sugar-free sweeteners containing sorbitol/xylitol.
• Consider soluble fibre such as psyllium, introduced gradually. It can make stools more consistently formed in both diarrhea and constipation phases.
• If urgency or cramps occur after meals, discuss an as-needed antispasmodic or peppermint-oil capsule with a pharmacist or clinician.
• Use loperamide only for genuinely loose/frequent stools or urgency, not simply because a stool occurs after a meal. Avoid it on constipated days.
• Keep a brief diary: meal, time to urge, stool form on the Bristol Stool Chart, pain/bloating, and stress. This often identifies individual triggers.

• you have recurrent abdominal pain related to bowel movements, at least about weekly over the last 3 months, with symptoms beginning at least 6 months ago, and
• more than 25% of bowel movements are loose or watery on the Bristol Stool Chart, types 6-7, and hard/lumpy stools are uncommon.

• No constipation: not IBS-M.
• Semi-solid stool after meals: may be a normal/functional post-meal bowel response, or could occur with IBS-D.
• IBS-D requires loose/watery stools plus recurrent abdominal pain, not merely frequent post-meal stooling.

1. Try this for 2-4 weeks

• Eat smaller, regular meals. Avoid large or high-fat meals.
• Reduce coffee/tea, alcohol, energy drinks, fizzy drinks, spicy food, fried foods, and sugar-free sweeteners containing sorbitol/xylitol.
• Consider a lactose-free trial for 2 weeks, especially if milk, ice cream, or whey worsen symptoms.
• Take psyllium husk (ispaghula) daily, starting with a small dose and increasing gradually with water. It can make loose stools more formed.
• Keep a food, timing, urgency, and stool-form diary.

2. For troublesome urgency or loose stools

• Loperamide can be used as needed, preferably before a predictable trigger such as travel or a meal that usually causes urgency. Follow the package directions or your clinician's advice. Do not exceed the labeled maximum, and do not use it if you are constipated, have fever, blood/black stool, or severe abdominal swelling/pain.
• Loperamide reduces stool frequency and urgency, but it may not improve bloating or abdominal pain.

3. For cramps or meal-related pain

• Ask a pharmacist/clinician about an as-needed antispasmodic or enteric-coated peppermint-oil capsule. Avoid peppermint oil if it triggers significant reflux/heartburn.

4. If symptoms remain frequent after the above

• Rifaximin, particularly for ongoing bloating and diarrhea
• Eluxadoline, but it must not be used in people without a gallbladder or those drinking more than three alcoholic drinks a day
• A low-dose tricyclic antidepressant for persistent bowel pain and urgency

Get assessed before self-treating long-term if

Practical treatment algorithm

1. Baseline measures

• Low-FODMAP diet: 2-6 week restriction, then reintroduction/personalization. Best delivered with a GI dietitian.
• Trial removal of obvious meal-related precipitants: caffeine, alcohol, high-fat meals, excess fructose/polyols, lactose if clinically suspected.
• Psyllium may improve global stool consistency. Start low and titrate to tolerance.
• Consider gut-directed CBT/hypnotherapy if refractory symptoms or prominent gut-brain interaction.

2. Stool frequency / urgency predominant

• 2 mg PRN or prophylactically before predictable trigger meals/travel; titrate to response.
• Typical total 2-16 mg/day, within local labeling.
• Useful for frequency, urgency, and incontinence, but does not reliably improve pain or bloating.

• Cholestyramine, colesevelam, or colestipol may be appropriate.

3. Global IBS-D symptoms, especially bloating and pain

• 550 mg orally three times daily for 14 days.
• Appropriate for persistent global IBS-D symptoms, particularly bloating.
• If there was a clear initial response and symptoms recur, repeat courses can be considered. AGA IBS-D guideline

4. Pain plus diarrhea

• Nortriptyline 10-25 mg nocte, or desipramine 10-25 mg nocte.
• Titrate slowly, commonly toward 25-50 mg nocte based on response and adverse effects.
• Obtain ECG/risk assessment when indicated, particularly with cardiac history, QT-prolonging drugs, or higher doses.
• In IBS-D, TCAs are often preferable to SSRIs because of analgesic and transit-slowing effects.

• Reasonable for meal-related colic/cramping. Choice depends on local availability, for example dicyclomine, hyoscine butylbromide, or mebeverine.
• Peppermint oil is an alternative if reflux is not problematic.

5. Refractory IBS-D

• 100 mg twice daily with food, or 75 mg twice daily in selected patients per local product information.
• Avoid/contraindicated with no gallbladder, biliary obstruction or sphincter of Oddi dysfunction, pancreatitis history, significant alcohol use, severe hepatic impairment, or severe constipation risk. The AGA specifically flags absent gallbladder and more than three alcoholic drinks/day. AGA recommendations

• Not a practical option for a male patient in most settings. It is generally restricted to women with severe refractory IBS-D because of ischemic colitis and severe constipation risk.

Suggested sequence in this case

1. Confirm true diarrhea versus frequent type 4-5 stool/strong gastrocolic reflex.
2. Diet trigger review plus low-dose psyllium.
3. PRN pre-emptive loperamide if urgency/frequency is functionally limiting.
4. Add antispasmodic or peppermint oil if cramping.
5. If persistent global symptoms with bloating, rifaximin.
6. If pain remains clinically important, add low-dose nortriptyline/desipramine.
7. Consider bile-acid diarrhea and eluxadoline only after phenotype/exclusion review.

• Clidinium: antimuscarinic antispasmodic
• Chlordiazepoxide: benzodiazepine anxiolytic

Where it fits

• Short, selected use for marked meal-related cramping/urgency with an anxiety component.
• Avoid using it continuously or escalating the dose.
• For chronic IBS-D, prefer phenotype-directed treatment: loperamide for urgency/frequency, antispasmodic without benzodiazepine exposure, low-dose TCA for pain-predominant disease, rifaximin for global bloating/diarrhea symptoms, and consideration of bile-acid diarrhea where appropriate.

Why not long-term

• tolerance, dependence, and withdrawal
• sedation, cognitive/psychomotor impairment and driving risk
• additive respiratory/CNS depression with alcohol, opioids, sedating antihistamines, gabapentinoids, etc.

Avoid or use extreme caution

• alcohol use, opioid use, substance-use disorder, or concurrent sedatives
• glaucoma
• prostatic enlargement/bladder outflow obstruction
• significant hepatic impairment
• suspected sleep apnea or respiratory compromise

Role in IBS-D

• Amitriptyline can be useful for IBS-D with clinically relevant abdominal pain, urgency, visceral hypersensitivity, sleep disturbance, or anxiety. It slows transit and acts as a gut-brain neuromodulator.
• Chlordiazepoxide does not treat IBS pathophysiology. It may transiently reduce anxiety-driven symptom amplification but introduces sedation, tolerance, dependence, and withdrawal risk.

Practical view

1. The benzodiazepine component is not desirable for maintenance therapy.
2. The amitriptyline dose is fixed, so you cannot independently titrate the TCA.
3. Sedation and psychomotor impairment are additive, especially with alcohol, opioids, antihistamines, gabapentinoids, or other CNS depressants.

• Librax: chlordiazepoxide + clidinium bromide
• Chlordiazepoxide + amitriptyline: often marketed as Limbitrol or as a local-brand generic combination